نتائج البحث - "Julian Walter Holch"

1

Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)

المؤلفون: Tobias Heintges, J. C. von Einem, Swantje Held, Christoph Kahl, Florian Kaiser, Marlies Michl, Alexander Kiani, Werner Scheithauer, L. Fischer von Weikersthal, Markus Moehler, Volker Heinemann, Frank Kullmann, Thomas Decker, Julian Walter Holch, Sebastian Stintzing

المصدر: Annals of Oncology. 31:72-78

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::079e82de852bda7021bd410425d991caTest
https://doi.org/10.1016/j.annonc.2019.10.001Test

2

Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study

المؤلفون: Jobst C. von Einem, Volker Heinemann, Kathrin Heinrich, Swantje Held, Dominik Paul Modest, Andreas Jung, Sebastian Stintzing, Alessia Fraccaroli, Werner Scheithauer, Michael Haas, Frank Kullmann, Ludwig Fischer von Weikersthal, Markus Moehler, Julian Walter Holch, Christoph Schulz

المصدر: Anti-cancer drugs. 31(8)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Renal Tubular Transport, Inborn Errors, Bevacizumab, Side effect, Colorectal cancer, Hypercalciuria, Leucovorin, Cetuximab, Irinotecan, Gastroenterology, Hypomagnesemia, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Magnesium, Aged, Retrospective Studies, Pharmacology, business.industry, Hazard ratio, medicine.disease, Prognosis, Survival Rate, Nephrocalcinosis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, FOLFIRI, Camptothecin, Female, Fluorouracil, business, Colorectal Neoplasms, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803dd08f49abea75d998cea6425575edTest
https://pubmed.ncbi.nlm.nih.gov/32639280Test

3

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

المؤلفون: Gerald Grütz, Marlies Michl, Martin K. Angele, Dominik Paul Modest, Volker Heinemann, Sylvia Peter, Peter J. Nelson, Christine Günther, Christiane Bruns, Hanno Niess, Hans-Dieter Volk, Oliver Stoetzer, Christoph Salat, Julian Walter Holch, Jobst C. von Einem

المصدر: Oncotarget

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f29a3a0dbd18bc47dc9694b3a4d029cTest
http://europepmc.org/articles/PMC5655186Test

4

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

المؤلفون: Ursula Vehling-Kaiser, Marlies Michl, Jobst C. von Einem, Andreas Jung, Thomas Kirchner, Julian Walter Holch, Andreas Schalhorn, Jens Neumann, Arndt Stahler, Sebastian Stintzing, D. Quietzsch, Stephan Kruger, Dominik Paul Modest, Alexander Crispin, Martina Stauch, Clemens Giessen-Jung, Volker Heinemann, Ludwig Fischer von Weikersthal, Michael J. Haas

المصدر: Anti-Cancer Drugs. 28:717-722

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, Receptor, ErbB-3, Receptor, ErbB-2, Colorectal cancer, Neuregulin-1, Leucovorin, Irinotecan, HER2/neu, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Humans, Pharmacology (medical), Neoplasm Metastasis, Retrospective Studies, Pharmacology, biology, business.industry, Hazard ratio, Retrospective cohort study, Prognosis, medicine.disease, Confidence interval, Oxaliplatin, Surgery, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Biomarker (medicine), Camptothecin, Fluorouracil, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bafc917324cff303ee44693f9cc45e8Test
https://doi.org/10.1097/cad.0000000000000510Test

5

The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials

المؤلفون: Volker Heinemann, Ingrid Ricard, Dominik Paul Modest, Julian Walter Holch, Sebastian Stintzing

المصدر: European Journal of Cancer. 70:87-98

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, medicine.medical_treatment, Angiogenesis Inhibitors, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Panitumumab, Randomized Controlled Trials as Topic, Retrospective Studies, Cetuximab, business.industry, Hazard ratio, Antibodies, Monoclonal, Prognosis, medicine.disease, Survival Analysis, Surgery, ErbB Receptors, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da836273e08d43d7d5de259ed578d52aTest
https://doi.org/10.1016/j.ejca.2016.10.007Test

6

Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer : A systematic review and meta-analysis

المؤلفون: Alexander Baraniskin, Wolff Schmiegel, Ulli Graeven, Julian Walter Holch, Barbara Buchberger, Christian Pox, Volker Heinemann

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Time Factors, Bevacizumab, Colorectal cancer, medicine.medical_treatment, MEDLINE, Cochrane Library, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, Randomized Controlled Trials as Topic, Chemotherapy, business.industry, Hazard ratio, Wirtschaftswissenschaften, medicine.disease, Progression-Free Survival, First line treatment, 030104 developmental biology, 030220 oncology & carcinogenesis, Meta-analysis, Disease Progression, Colorectal Neoplasms, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024d48a47a2f7dfded17de8b88201712Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85056809277Test

7

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

المؤلفون: Ingrid Ricard, J. C. von Einem, Christoph Kahl, Christoph B. Westphalen, Werner Scheithauer, Marlies Michl, M. Moehler, Ursula Vehling-Kaiser, Dominik Paul Modest, Sebastian Stintzing, Tobias Heintges, Ivan Jelas, Alexander Kiani, Frank Kullmann, Volker Heinemann, L. Fischer von Weikersthal, Thomas Decker, Julian Walter Holch

المصدر: European journal of cancer (Oxford, England : 1990). 106

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Time Factors, Colorectal cancer, Leucovorin, Cetuximab, medicine.disease_cause, Gastroenterology, 0302 clinical medicine, Carcinoembryonic antigen, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, biology, Hazard ratio, Middle Aged, Progression-Free Survival, Up-Regulation, Bevacizumab, Oncology, 030220 oncology & carcinogenesis, FOLFIRI, Female, KRAS, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, medicine, Humans, neoplasms, Aged, Retrospective Studies, business.industry, Odds ratio, medicine.disease, digestive system diseases, Carcinoembryonic Antigen, 030104 developmental biology, Clinical Trials, Phase III as Topic, biology.protein, Camptothecin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db427639897a9a8442afe5d29fcf7f1fTest
https://pubmed.ncbi.nlm.nih.gov/30496943Test

8

Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)

المؤلفون: Andreas Schalhorn, Clemens Giessen-Jung, Dominik Paul Modest, Alexander Crispin, J. C. von Einem, Ursula Vehling-Kaiser, Jens Neumann, Arndt Stahler, Martina Stauch, Volker Heinemann, T. Kirchner, Sebastian Stintzing, Swantje Held, Andreas Jung, D. Quietzsch, L. Fischer von Weikersthal, Julian Walter Holch

المصدر: International Journal of Cancer. 138:739-746

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::12e4a3412ea00963fd5d4f8062d6ff23Test
https://doi.org/10.1002/ijc.29807Test

تنقيح النتائج